Similar tumor microenvironment remodeling as a function of CD40 stimulation has been reported by other groups in different models [56, 57], indicating a common theme that above and beyond DC priming, CD40 can promote a proimmunity landscape within tumors. This evidence concerns the gene CD40 and neoplasm.